Selective serotonin reuptake inhibitor effects on neural biomarkers of perinatal depression - Université de Rennes Access content directly
Journal Articles Archives of Women's Mental Health Year : 2019

Selective serotonin reuptake inhibitor effects on neural biomarkers of perinatal depression

Abstract

The effect of perinatal selective serotonin reuptake inhibitors (SSRIs) on brain-derived neurotrophic factor (BDNF) and S100 calcium binding protein B (S100B) has not been investigated. Using a cohort of 86 pregnant women, we found that SSRIs significantly increase BDNF levels in late pregnancy and that S100B, but not BDNF, is associated with maternal depression in SSRI-treated women only. This shows that serum S100B could be a unique biomarker to determine efficacy of SSRIs during gestation.
Fichier principal
Vignette du fichier
Pawluski_Selective Serotonin Reuptake Inhibitor Effects_Accepted.pdf (97.15 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01976469 , version 1 (14-01-2019)

Identifiers

Cite

Jodi L Pawluski, Ursula Brain, Geoffrey L Hammond, Tim F Oberlander. Selective serotonin reuptake inhibitor effects on neural biomarkers of perinatal depression. Archives of Women's Mental Health, 2019, 22 (3), pp.431-435. ⟨10.1007/s00737-018-0931-1⟩. ⟨hal-01976469⟩
127 View
328 Download

Altmetric

Share

Gmail Facebook X LinkedIn More